Papers

1

Total Citations

10

H-Index

1

About

Dr. Sabrina Rossetti is a leading urologic oncologist whose research centers on advancing surgical management for testicular cancer, particularly through minimally invasive techniques. Her most impactful work focuses on robot-assisted retroperitoneal lymph node dissection (RPLND) for patients with Stage II non-seminomatous germ cell tumors. In her highly cited 2023 study, she demonstrated the safety and efficacy of a unilateral, modified-template approach to post-chemotherapy RPLND, a critical procedure for removing residual disease after systemic therapy. By championing robotic assistance, Dr. Rossetti has helped reduce the significant morbidity traditionally associated with open RPLND, including shorter hospital stays and faster recovery. Her contributions are vital in refining surgical templates to minimize collateral damage while maintaining oncologic rigor. With her work garnering attention in the field, Dr. Rossetti is shaping the standard of care for young men facing this challenging disease, offering a path to cure with less surgical burden. Her ongoing research continues to push the boundaries of precision surgery in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor: A tertiary care experience
10 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago